Five routine tests provide limited clinical value, and evidence-based alternatives can better guide diagnosis, risk for ...
"Eledon takes transplant rejection therapy to Phase III on mixed results" was originally created and published by Clinical ...
Health officials said no humans encountered the bats, but a dog that was up to date on vaccinations was exposed.
Takeda (TSE:4502/NYSE:TAK) today announced that the recently FDA-approved HyHub and HyHub Duo devices are now available in the U.S. for patients 17 years of age and older, as prescribed, who are ...
Detailed price information for Takeda Pharmaceutical Ltd ADR (TAK-N) from The Globe and Mail including charting and trades.
The researchers argue that the integration of explainable AI into clinical decision-making pipelines could reshape cancer ...
Third Quarter 2025 Financial Results: Total revenue for the quarter ended September 30, 2025 was $134.2 million, up 12% from $119.8 million in the same period of 2024. This growth and operational ...
An updated guide to timing, parts, costs and coordination so you don’t get stuck with penalties or surprises at 65.
You spot the same wiry chin hair again. It returns quickly, raising awkward questions about timing, stress, age and hormones.
Homeownership can be really overrated. But we finally decided to go with a non-digging option, called an “epoxy patch liner,” that would be threaded through the existing pipe through those cleanouts ...
DJ Carey faked letters from US doctors in which they praised his ‘staggering’ bravery in the face of cancer, it has emerged.
Planning to initiate an open-label Phase 2 study of TNX-1500 under an investigator-initiated IND to evaluate safety and activity in the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results